Drugs / poly (cinnamyl alcohol-RPol(POL)
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07066527 Background | Jun 2022 → Dec 2025 overdue | vascular malformation | Qilu Hospital of Shandong University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | poly (cinnamyl alcohol-RPol(POL) | “According to the study, the half-life of 1% poly (cinnamyl alcohol-RPol(POL) foam with a liquid-to-gas ratio of 1:4 was 142.8(64.32) seconds” NCT07066527 ↗ |
| Known as | POL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07066527 ↗ |